Association Among Lipid Accumulation Product, Chinese Visceral Obesity Index and Diabetic Retinopathy in Patients with Type 2 Diabetes: A Cross-Sectional Study
Xin Li,Hui-Yao Li,Zi-Wei Yu,Yi-Tong Zhang,Xue-Wei Tong,Xin-Yuan Gao
DOI: https://doi.org/10.2147/DMSO.S348195
2021-12-30
Abstract:Xin Li, &ast Hui-Yao Li, &ast Zi-Wei Yu, Yi-Tong Zhang, Xue-Wei Tong, Xin-Yuan Gao The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, 150001, People's Republic of China &astThese authors contributed equally to this work Correspondence: Xin-Yuan Gao Department of Endocrinology, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, 150001, People's Republic of China Tel +86 13904517001 Email Background and Aim: Obesity often coexists with diabetes, especially abdominal obesity, recognized as a risk factor for diabetic complications. Diabetic retinopathy (DR), as one of the most common microvascular complications of diabetes, may be associated with these indices. Lipid accumulation product (LAP) and Chinese visceral obesity index (CVAI) are novel visceral obesity indicators, which have been proven to be an influential factor predicting type 2 diabetes (T2DM). However, the correlation among LAP, CVAI, and DR still lacks systematic research in T2DM. The study aimed to explore the relationship among LAP, CVAI levels in different DR stages of T2DM patients and the diagnostic efficacy of LAP and CVAI for DR. Methods: A total of 263 participants were recruited in this cross-sectional study. We enrolled 169 patients with T2DM, divided into the non-DR group (NDR, n = 61), non-proliferative DR group (NPDR, n = 55), and proliferative DR group (PDR, n = 53). And we also enrolled 94 healthy control participants. We collected demographic, anthropometric, and biochemical data on each subject. LAP and CVAI are calculated according to different formulas for men and women. Results: Compared with the control group, LAP and CVAI were significantly higher (P < 0.05). After adjusting for confounding factors, LAP (OR: 1.029, 95CI%: 1.010– 1.049, P < 0.05), WC (OR: 1.073, 95CI%: 1.009– 1.141, P < 0.05) and CVAI (OR: 1.017, 95CI%: 1.000– 1.033, P < 0.05) were all associated with an increased risk of DR. Furthermore, increased LAP (OR: 1.020, 95% CI: 0.100– 0.290) is associated with DR severity (P < 0.001). Moreover, the LAP had the most significant area under the receiver operating characteristics (ROC) curve (AUC) (AUC = 0.728, 95% CI: 0.653– 0.804). Conclusion: A high LAP is associated with an increased risk of DR in T2DM patients, and the LAP index appears to be a good predictor of DR risk and severity in patients with T2DM, compared with BMI, WC, and CVAI. Keywords: lipid accumulation product, LAP, Chinese visceral obesity index, CVAI, diabetic retinopathy, DR, abdominal/visceral obesity Diabetes mellitus (DM) is a chronic disease characterized by hyperglycemia, which can cause a variety of macrovascular and microvascular complications. In 2019, approximately 4.2 million people worldwide died of DM and its complications. 1 DR is the most common microvascular complication of DM and is also one of the causes of blindness in working-age adults. 2 The prevalence of DM in China ranks the first globally, and DR affects about one-fifth of the patients with diabetes, 3 which is vital to identify its screening criteria. About the epidemiological data, the worldwide prevalence of overweight and obesity has reached 33.3%, which has doubled since 1980. 4 Moreover, obesity, especially abdominal obesity, has been an important risk factor for T2DM. 5 In addition, studies have shown that abdominal/visceral obesity is closely related to DR in long-term T2DM patients. 6 However, the methods to detect abdominal adiposity include dual-energy X-ray absorptiometry (DEXA), computed tomography (CT), magnetic resonance imaging (MRI), and dual bioelectrical impedance analysis (BIA). Also, they are unsuitable for routine clinical practices in a general population because of the radiation exposure, time requirements, and high costs. 7 This study will propose two new indices—LAP and CVAI. LAP is a new indicator of visceral obesity based on triglycerides and waist circumference. 8 Studies have shown that LAP index is a powerful factor predicting cardiovascular disease, 9,10 metabolic syndrome (MetS), 11 insulin resistance, 12 and type 2 diabetes. 13,14 A study of Wu et al 15 has shown that a higher LAP index was associated with a lower risk of DR. But a new study by Wan et al showed that CVAI was not associated with the prevalence of DR. 7 However, there is still a lack of systematic exploration on the relationship among LAP index, CVAI, and DR in T2DM patients. Therefore, the purpose of our study was to explore the changes of LAP and CVAI levels at different stages of DR and to evaluate the diagnostic efficacy -Abstract Truncated-